"Il Pascale è il maggiore IRCCS Oncologico del Mezzogiorno ed è Centro di Riferimento per la rete oncologica nazionale e regionale. L'Istituto persegue finalità di ricerca prevalentemente clinica, e di ricerca applicata nel campo biomedico e in quello dell'organizzazione e gestione dei servizi sanitari, dedicando grande impegno alle problematiche più ampie del paziente oncologico, che vanno dall'assistenza psicologica ai problemi nutrizionali, alla terapia del dolore, alle cure palliative in genere, fino alle fasi più delicate della malattia."

During the past decade, National Cancer Institute of Naples conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Institute of Naples" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator and "Federico II University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "National Cancer Institute of Naples" are "Brain Metastases" (1 trials), "COVID-19 Pneumonia" (1 trials), "Cancer Pain" (1 trials), "GEP Neuroendocrine Tumor" (1 trials) and "Intraoperative Complications" (1 trials). Many other conditions were trialed in "National Cancer Institute of Naples" in a lesser frequency.

Most popular intervention types in "National Cancer Institute of Naples" are "Drug" (4 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cabozantinib and Temozolomide" (1 trials), "Fotemustine" (1 trials), "Fotemustine and Ipilimumab" (1 trials), "Ipilimumab and Fotemustine" (1 trials) and "Ipilimumab and nivolumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Cancer Institute of Naples" are 7 trials for "All" genders.

Currently, there are NaN active trials in "National Cancer Institute of Naples". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in National Cancer Institute of Naples, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Cancer Institute of Naples, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".